Cost collection and analysis for health economic evaluation

Otolaryngology - Head and Neck Surgery (United States)

Volumn 149, Issue 2, 2013, Pages 192-199

  Smith, Kristine A ^a   Rudmik, Luke ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

accounting; cost analysis; cost collection; cost effectiveness; cost estimation; economic evaluation; health care

Indexed keywords

BIBLIOGRAPHIC DATABASE; CLINICAL PROTOCOL; COCHRANE LIBRARY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSIS RELATED GROUP; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEALTH ECONOMICS; HUMAN; MEDLINE; NATIONAL HEALTH SERVICE; OTORHINOLARYNGOLOGY; PATIENT CARE; PRODUCTIVITY; RESOURCE ALLOCATION; REVIEW; SAMPLE SIZE; SYSTEMATIC REVIEW; UNCERTAINTY;

ACCOUNTING; COST ANALYSIS; COST COLLECTION; COST EFFECTIVENESS; COST ESTIMATION; ECONOMIC EVALUATION; HEALTH CARE;

COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; STATE MEDICINE; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 84884177588     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599813487850     Document Type: Review

References (22)

1. Neumann PJ. What we talk about when we talk about health care costs. N Engl J Med. 2012 ; 366: 585-586
2. Snyder L. American College of Physicians Ethics Manual: Sixth Edition. Ann Intern Med. 2012 ; 156: 73-104
3. Task Force on Principles for Economic Analysis of Health Care Technology. Ann Intern Med. 1995 ; 123: 61-70
4. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ. 1996 ; 313: 275-283
5. Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996 ; 276: 1339-1341
6. Drummond M, Coyle D. The role of pilot studies in the economic evaluation of health technologies. Int J Technol Assess Health Care. 1998 ; 14: 405-418
7. Miners A. Estimating 'costs' for cost-effectiveness analysis. Pharmacoeconomics. 2008 ; 26: 745-751
8. Johnston K, Buxton MJ, Jones DR, Fitzpatrick R. Assessing the costs of healthcare technologies in clinical trials. Health Technol Assess. 1999 ; 3: 1-76
9. HCUPnet. http://hcupnet.ahrq.gov/. Accessed March 2013.
10. Ontario guidelines for economic analysis of pharmaceutical products. http://www.health.gov.on.ca/english/providers/pub/drugs/economic/economic-mn. html. Accessed March 2013.
11. National Institute of Clinical Excellence. Guide to the methods of technology appraisal. http://www.nice.org.uk/media/B52/A7/ TAMethodsGuideUpdatedJune2008.pdf. Accessed March 2013.
12. Drummond MF, Schulpher MJ, Torrance GW, O'Brien BJ, Stoddart GL Methods for the economic evaluation of health care programmes. 3 rd ed.Oxford, UK: Oxford University Press; 2005. Oxford, UK: Oxford University Press ; 2005 :
13. Jackson CH, Bojke L, Thompson SG, Claxton K, Sharples LD. A framework for addressing structural uncertainty in decision models. Med Decis Making. 2011 ; 31: 662-674
14. Bojke L, Claxton K, Sculpher M, Palmer S. Characterizing structural uncertainty in decision analytic models: a review and application of methods. Value Health. 2009 ; 12: 739-749
15. Fenwick E, Marshall DA, Levy AR, Nichol G. Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation. BMC Health Serv Res. 2006 ; 6: 52
16. Meltzer D. Addressing uncertainty in medical cost-effectiveness analysis implications of expected utility maximization for methods to perform sensitivity analysis and the use of cost-effectiveness analysis to set priorities for medical research. J Health Econ. 2001 ; 20: 109-129
17. Briggs AH, Gray AM. Handling uncertainty in economic evaluations of healthcare interventions. BMJ. 1999 ; 319: 635-638
18. Shepard DS J Ment Health Policy Econ. Gold M. R. Siegel J. E. Russell L. B. Weinstein M. C., ed. New York: Oxford University Press ; 1996 1999: 91-92.
19. Jacob-Tacken KH, Koopmanschap MA, Meerding WJ, Severens JL. Correcting for compensating mechanisms related to productivity costs in economic evaluations of health care programmes. Health Econ. 2005 ; 14: 435-443
20. Goeree R, O'Brien BJ, Blackhouse G, Agro K, Goering P. The valuation of productivity costs due to premature mortality: a comparison of the human-capital and friction-cost methods for schizophrenia. Can J Psychiatry. 1999 ; 44: 455-463
21. Koopmanschap MA, Rutten FF, van Ineveld BM, van Roijen L. The friction cost method for measuring indirect costs of disease. J Health Econ. 1995 ; 14: 171-189
22. Koopmanschap MA, Rutten FF. A practical guide for calculating indirect costs of disease. Pharmacoeconomics. 1996 ; 10: 460-466